1
40
2
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
URL Address
<a href="http://doi.org/10.1097/MJT.0b013e3181d48320" target="_blank" rel="noreferrer noopener">http://doi.org/10.1097/MJT.0b013e3181d48320</a>
Pages
300–304
Issue
4
Volume
18
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Comparison of short-acting intramuscular antipsychotic medication: impact on length of stay and cost.
Publisher
An entity responsible for making the resource available
American Journal of Therapeutics
Date
A point or period of time associated with an event in the lifecycle of the resource
2011
2011-07
Subject
The topic of the resource
Adult; Female; Male; Prospective Studies; Health Care Costs; Injections; Middle Age; Retrospective Design; Intramuscular; Antiinfective Agents; Length of Stay – Statistics and Numerical Data; Schizophrenia – Drug Therapy; Heterocyclic Compounds – Therapeutic Use; Antianxiety Agents; Antipsychotic Agents – Administration and Dosage; Antipsychotic Agents – Economics; Antipsychotic Agents – Therapeutic Use; Benzodiazepine – Economics; Benzodiazepine – Therapeutic Use; Haloperidol – Economics; Haloperidol – Therapeutic Use; Heterocyclic Compounds – Economics; Length of Stay – Economics; Psychomotor Agitation – Drug Therapy; Quinolone – Economics; Quinolone – Therapeutic Use; Thiazoles – Economics; Thiazoles – Therapeutic Use
Creator
An entity primarily responsible for making the resource
Leung JG; Benedetti AM; Frazee L A; Myers N; Leung Jonathan G; Benedetti Amanda M; Frazee Lawrence A; Myers Nancy
Description
An account of the resource
A retrospective cohort study was conducted to determine if there is an association between short-acting intramuscular (SAIM) antipsychotics used for acute agitation and length of stay (LOS). Patients with a diagnosis of schizophrenia or schizoaffective disorder who were dispensed at least one dose of a SAIM antipsychotic were divided into groups based on the initial SAIM antipsychotic received once admitted to a psychiatric unit. Electronic records were used to gather demographic information, LOS, and number of injections received during an admission. Cost was calculated from the number of injections received. One-hundred and thirty-six patients were enrolled. When comparing the haloperidol group to the second generation antipsychotic group, there was no statistically significant difference, in LOS 16.98 ± 9.56 days versus 17.59 ± 11.52 days (P = 0.75), respectively. There was a statistically significant difference in both cost and number of injections between groups, favoring the haloperidol group. Ziprasidone was associated with a shorter LOS compared with olanzapine, 13.57 and 19.10 days, respectively (P = 0.026). Patient characteristics should be evaluated when determining an agent for acute agitation. However, because literature indicates second generation SAIM antipsychotics are only noninferior to haloperidol; other factors should also be evaluated; including impact on LOS and impact on hospital resources. This study indicates use of a second generation SAIM antipsychotic for acute agitation is more costly, requires more injections, and was not associated with a shorter length of stay when compared with SAIM haloperidol.
Identifier
An unambiguous reference to the resource within a given context
<a href="http://doi.org/10.1097/MJT.0b013e3181d48320" target="_blank" rel="noreferrer noopener">10.1097/MJT.0b013e3181d48320</a>
Rights
Information about rights held in and over the resource
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
2011
Adult
American journal of therapeutics
Antianxiety Agents
Antiinfective Agents
Antipsychotic Agents – Administration and Dosage
Antipsychotic Agents – Economics
Antipsychotic Agents – Therapeutic Use
Benedetti AM
Benedetti Amanda M
Benzodiazepine – Economics
Benzodiazepine – Therapeutic Use
Department of Family & Community Medicine
Department of Internal Medicine
Female
Frazee L A
Frazee Lawrence A
Haloperidol – Economics
Haloperidol – Therapeutic Use
Health Care Costs
Heterocyclic Compounds – Economics
Heterocyclic Compounds – Therapeutic Use
Injections
Intramuscular
Length of Stay – Economics
Length of Stay – Statistics and Numerical Data
Leung JG
Leung Jonathan G
Male
Middle Age
Myers N
Myers Nancy
NEOMED College of Medicine
Prospective Studies
Psychomotor Agitation – Drug Therapy
Quinolone – Economics
Quinolone – Therapeutic Use
Retrospective Design
Schizophrenia – Drug Therapy
Thiazoles – Economics
Thiazoles – Therapeutic Use
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
URL Address
<a href="http://doi.org/10.1161/CIRCULATIONAHA.112.146100" target="_blank" rel="noreferrer noopener">http://doi.org/10.1161/CIRCULATIONAHA.112.146100</a>
Pages
2677–2679
Issue
23
Volume
126
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Novel mechanisms for maintaining endothelial barrier function in sepsis.
Publisher
An entity responsible for making the resource available
Circulation
Date
A point or period of time associated with an event in the lifecycle of the resource
2012
2012-12-04
Subject
The topic of the resource
Male; Animals; Capillary Permeability – Physiology; Endothelium – Metabolism; Heterocyclic Compounds – Therapeutic Use; Pulmonary Edema – Drug Therapy; Pulmonary Edema – Metabolism
Creator
An entity primarily responsible for making the resource
Penn M S; Kamath M
Identifier
An unambiguous reference to the resource within a given context
<a href="http://doi.org/10.1161/CIRCULATIONAHA.112.146100" target="_blank" rel="noreferrer noopener">10.1161/CIRCULATIONAHA.112.146100</a>
Rights
Information about rights held in and over the resource
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
2012
Animals
Capillary Permeability – Physiology
Circulation
Endothelium – Metabolism
Heterocyclic Compounds – Therapeutic Use
Kamath M
Male
Penn M S
Pulmonary Edema – Drug Therapy
Pulmonary Edema – Metabolism